Morgan Stanley
BDMD

Morgan Stanley’s Baird Medical Investment Holdings BDMD Stock Holding History

Morgan Stanley’s Portfolio BDMD Stock Details BDMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$39.2K – 8642
2026
Q1 		$39.2K Buy
+20,000
New +$33.4K ﹤0.01% 6509
2025
Q3 		– Sell
-8,734
Closed -$32K – 8425
2025
Q2 		$32K Sell
8,734
-4,433
-34% -$23.2K ﹤0.01% 6503
2025
Q1 		$68.6K Buy
+13,167
New +$78.9K ﹤0.01% 6165

Other funds holding BDMD

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Morgan Stanley's BDMD Position: Q2 2026 in Review

Morgan Stanley sold out of Baird Medical Investment Holdings (BDMD) in Q2 2026, closing a stake of 20,000 shares — an estimated $39.2K sold.

Morgan Stanley first reported a position in BDMD in Q1 2025 and held it in 3 quarters. The position peaked at $68.6K in Q1 2025. 10 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.

  • Morgan Stanley reported no remaining Baird Medical Investment Holdings position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 20,000 Baird Medical Investment Holdings shares in Q2 2026, an estimated $39.2K.
  • Morgan Stanley first reported a position in Baird Medical Investment Holdings in Q1 2025 and held it in 3 quarters.
  • Morgan Stanley's Baird Medical Investment Holdings position peaked at $68.6K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.